首页> 外文期刊>Drug Design, Development and Therapy >Integrated Network Pharmacology Analysis and Experimental Validation to Reveal the Mechanism of Anti-Insulin Resistance Effects of Moringa oleifera Seeds
【24h】

Integrated Network Pharmacology Analysis and Experimental Validation to Reveal the Mechanism of Anti-Insulin Resistance Effects of Moringa oleifera Seeds

机译:综合网络药理学分析和实验验证,揭示了辣木抗胰岛素抗性抗性作用机制

获取原文
           

摘要

Background and Purpose: Insulin resistance (IR) is one of the factors that results in metabolic syndrome, type 2 diabetes mellitus and different aspects of cardiovascular diseases. Moringa oleifera seeds (MOS), traditionally used as an antidiabetic food and traditional medicine in tropical Asia and Africa, have exhibited potential effects in improving IR. To systematically explore the pharmacological mechanism of the anti-IR effects of MOS, we adopted a network pharmacology approach at the molecular level. Methods: By incorporating compound screening and target prediction, a feasible compound-target-pathway network pharmacology model was established to systematically predict the potential active components and mechanisms of the anti-IR effects of MOS. Biological methods were then used to verify the results of the network pharmacology analysis. Results: Our comprehensive systematic approach successfully identified 32 bioactive compounds in MOS and 44 potential targets of these compounds related to IR, as well as 37 potential pathways related to IR. Moreover, the network pharmacology analysis revealed that glycosidic isothiocyanates and glycosidic benzylamines were the major active components that improved IR by acting on key targets, such as SRC, PTPN1, and CASP3, which were involved in inflammatory responses and insulin-related pathways. Further biological research demonstrated that the anti-IR effects of MOS were mediated by increasing glucose uptake and modulating the expression of SRC and PTPN1. Conclusion: Our study successfully predicts the active ingredients and potential targets of MOS for improving IR and helps to illustrate mechanism of action at a systemic level. This study not only provides new insights into the chemical basis and pharmacology of MOS but also demonstrates a feasible method for discovering potential drugs from traditional medicines.
机译:背景论:胰岛素抵抗(IR)是导致代谢综合征,2型糖尿病和心血管疾病的不同方面的因素之一。传统上用作热带亚洲和非洲的抗糖尿病食品和传统医学的辣木,传统上用作改善IR的潜在影响。为了系统地探索MOS的抗红外效应的药理机制,我们采用了分子水平的网络药理学方法。方法:通过掺入复合筛选和靶预测,建立了一种可行的复合目标 - 途径网络药理学模型,以系统地预测MOS的抗红外效应的潜在活性成分和机制。然后使用生物方法来验证网络药理学分析的结果。结果:我们综合的系统方法在MOS和44个与IR相关的这些化合物的潜在靶标中成功地确定了32个生物活性化合物,以及与IR相关的37个潜在途径。此外,网络药理学分析显示,糖苷异硫氰酸酯和糖苷苄胺是通过作用于关键靶标,例如SRC,PTPN1和CASP3的主要活性成分,例如参与炎症反应和胰岛素相关的途径。进一步的生物学研究表明,通过增加葡萄糖摄取和调节SRC和PTPN1的表达来介导MOS的抗红外效应。结论:我们的研究成功地预测了用于改善IR的MOS的活性成分和潜在目标,并有助于说明在系统水平下的作用机制。本研究不仅为MOS的化学基础和药理提供了新的见解,而且还证明了发现来自传统药物的潜在药物的可行方法。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号